US2024268445A1PendingUtilityA1

Composition for smokeless tobacco and orally dissolvable film-type smokeless tobacco comprising same

Assignee: C L PHARM CO LTDPriority: Mar 9, 2018Filed: Mar 12, 2024Published: Aug 15, 2024
Est. expiryMar 9, 2038(~11.6 yrs left)· nominal 20-yr term from priority
Inventors:Seok Hoon Chang
A24B 15/186A24B 15/16A24B 15/18A24B 15/302A24B 13/00
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a composition for smokeless tobacco and orally dissolvable film-type smokeless tobacco comprising same. More specifically, the present invention relates to a composition for orally dissolvable film-type smokeless tobacco, which is capable of improving the intraoral uptake rate, moldability, and taste of nicotine while reducing harmfulness to the human body, orally dissolvable film-type smokeless tobacco comprising same, and a manufacturing method thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An orally dissolvable film-type smokeless tobacco comprising:
 a first region formed by coating a composition for the smokeless tobacco in a film form, and   a second region formed by coating a flavor composition, a functional food composition, a beauty treatment composition, a pharmaceutical composition, or a mixture thereof in the film form to be adjacent to the first region in parallel,   wherein the composition for smokeless tobacco contains:   a nicotine activator of 0.01 to 4 parts by weight;   a binder of 40 to 80 parts by weight; and   a plasticizer of 2 to 10 parts by weight.   
     
     
         2 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein the nicotine activator is nicotine oil and has a purity equal to or above 99%. 
     
     
         3 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein the binder is hydroxypropylmethylcellulose or hydroxypropylcellulose. 
     
     
         4 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein the binder is contained in 40 to 60 parts by weight. 
     
     
         5 . The orally dissolvable film-type smokeless tobacco of  claim 1 , further containing water as a solvent. 
     
     
         6 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein viscosity is 15,000±5,000 cps. 
     
     
         7 . The orally dissolvable film-type smokeless tobacco of  claim 1 , further containing:
 a flavor; and   at least one of a surfactant, a sweeting agent, and a coloring agent.   
     
     
         8 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein at least one of the composition for the smokeless tobacco, the flavor composition, the functional food composition, the beauty treatment composition, the pharmaceutical composition, and the mixture thereof further contains a coloring agent. 
     
     
         9 . The orally dissolvable film-type smokeless tobacco of  claim 1 , wherein the smokeless tobacco is disintegrated within 5 minutes after being placed in an oral cavity. 
     
     
         10 . A method for manufacturing an orally dissolvable film-type smokeless tobacco, the method comprising:
 discharging a composition for a smokeless tobacco in a single dose through a first nozzle such that the discharged composition is coated on a packaging material, thereby forming a first region;   discharging a flavor composition, a functional food composition, a beauty treatment composition, a pharmaceutical composition, or a mixture thereof in a single dose through a second nozzle such that the discharged composition is coated on the packaging material adjacent to the first region in parallel, thereby forming a second region; and   drying the first region and the second region;   wherein the composition for smokeless tobacco contains:   a nicotine activator of 0.01 to 4 parts by weight;   a binder of 40 to 80 parts by weight; and   a plasticizer of 2 to 10 parts by weight.   
     
     
         11 . The method of  claim 10 , wherein the drying of the first region and the second region is performed at a temperature in a range from 50 to 90° C.

Join the waitlist — get patent alerts

Track US2024268445A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.